RCE 0.00% 48.5¢ recce pharmaceuticals ltd

Ann: HREC Approval to Start Phase I/II Burns Wound Study, page-33

  1. 7,276 Posts.
    lightbulb Created with Sketch. 1129
    Well I am surprised this has gone down on such good news. 'Theoretically' the sign of a weak stock - oh well just have to look for a top into my LT holdings.

    My reading of it is phase 1/2 human tropical with phase 1 human IV in parallel / side by side. They are not so specific on IV timelines etc in IV ann said screening Q4 2020 so could be happening now & 48 IV test candidates ready to run 'in parallel' with 30 tropical candidates. 'in parallel' is open to interpretation at present.

    A$30 Mil in the bank to progress this, have the green light for phase 1 & 2 human tropic & phase 1 human IV 'in parallel' - I'm liking it.

    https://hotcopper.com.au/data/attachments/2565/2565573-9177234b09bc399852640ddb303ce8d9.jpg

    IV

    https://themarketherald.com.au/recce-pharmaceuticals-asxrce-enlists-cmax-clinical-research-for-phase-1-study-2020-09-11/

    https://hotcopper.com.au/data/attachments/2565/2565590-38ea8c8003569a46179e16c7190e04df.jpg
    .


    .
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
48.5¢
Change
0.000(0.00%)
Mkt cap ! $112.3M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 15892 48.5¢
 

Sellers (Offers)

Price($) Vol. No.
48.5¢ 2004 2
View Market Depth
Last trade - 09.55am 30/08/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.